Physicians' Academy for Cardiovascular Education

Is inflammation reduction key for targeting residual risk, beyond lowering LDL-c?

Oct. 18, 2014 - Snapshot 2014 - Prof. Paul M Ridker, MD



Dr. Paul Ridker, Boston describes the different inflammatory pathways and ongoing clinical trials targeting inflammation
Recorded during the PAC Snapshot session in Barcelona 2014